Navigation Links
Orqis(R) Medical Awarded 15th U.S. Patent
Date:4/23/2008

Intellectual Property Expands to 41 Patents in more than 20 Countries

LAKE FOREST, Calif., April 23 /PRNewswire/ -- Orqis(R) Medical Corporation, a medical products company developing and marketing devices to improve cardiac performance through Aortic Flow Therapy, announced today that the United States Patent and Trademark Office has issued U.S. Patent number 7,331,921 (the '921 patent) entitled "Implantable Heart Assist System and Method of Applying Same." The '921 patent which discloses and claims methods and apparatus for intravascular renal (kidney) perfusion is exclusively owned by Orqis and is the Company's 15th U.S. Patent.

Mr. Ken Charhut, President and CEO, Orqis Medical, stated, "This latest patent is the result of Orqis' aggressive intellectual property strategy to treat the cardio-renal syndrome and improve cardiac performance with less invasive treatment approaches." He continued, "Orqis is developing a large intellectual property footprint that addresses the treatment gap between medical management and more invasive procedures without ever touching the heart."

Orqis' patent portfolio now encompasses 15 U.S. Patents and 26 International Patents in over 20 countries.

About Heart Failure

Over 5 million Americans suffer from heart failure, a condition in which the heart becomes weakened and cannot pump blood efficiently. Heart failure is caused by coronary artery disease, past myocardial infarctions, cardiomyopathy and other underlying cardiovascular disorders, and it is characterized by shortness of breath, functional impairment, and edema. In the U.S., heart failure results in over 1 million hospitalizations annually and is responsible for over $33 billion in direct and indirect costs to the U.S. healthcare system each year.

About Orqis Medical Corporation

Orqis Medical Corporation is a privately held medical device company that develops and sells minimally invasive devices that improve cardiac performance through aortic flow therapy. Orqis devices uniquely bridge the treatment gap between medical management and more invasive procedures without ever touching the heart. The percutaneous Cancion System has secured the CE mark. The implantable Exeleras(R) System is in development.

For more information on Orqis Medical, please visit orqis.com

Note: Orqis(R), Cancion(R), and Exeleras(R) are registered trademarks of Orqis Medical Corporation.


'/>"/>
SOURCE Orqis Medical Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Orqis(R) Medicals MOMENTUM Trial Abstract Accepted for Late Breaking Clinical Trial Presentation at the American College of Cardiology Annual Meeting
2. Best Practice Database Adds New Research on Effective Sales Force Incentives and Continuing Medical Education
3. First-Quarter 2008 Results Teleconference/Webcast for VNUS Medical Technologies Interrupted Due to Technical Difficulties
4. Select Medical Corporation Makes Historic Multi-Million Dollar Gift to Harrisburg University
5. Developing roadmaps for enhancing the professional culture of medical schools
6. UT Southwestern Medical Center receives grant from the Robert Wood Johnson Foundation
7. The Womens Health II Medical Education Network Raises Awareness About the Diagnosis and Management of Womens Health Issues
8. Changes to Family and Medical Leave Act Clarify Employer Responsibilities
9. Medical Breakthrough Reaches America
10. CRH Medical Corporation opens third Center in Chicago
11. Medicare to consider public opinion about medical maggots
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2016)... ... ... Francesca Loparco, Co-Founder of Queen City Dream Cars, an exotic car rental business ... at Christenbury Eye Center. The entrepreneur struggled with her computer, riding horses and driving ... her in-office consultation and eye exam. Francesca’s eyesight was restored to 20/20 in both ...
(Date:5/4/2016)... ... May 04, 2016 , ... Pharmacy Times , the ... was chosen as the Pharmaceutical News Provider of the Year in the inaugural ... hard work and dedication of community members who strive to make the pharmaceutical ...
(Date:5/4/2016)... ... May 04, 2016 , ... Bayco ... compact tactical (6.7 inch) dual-light flashlights in models NSP-9842XL and NSR-9844XL . ... retail starting at $59.95) uses 2 included CR-123 batteries to produce up to ...
(Date:5/4/2016)... ... May 04, 2016 , ... AudioEducator is the country's top ... months, AudioEducator has lined up some informative training session for the medical coding ... compliance know-how and practical, easy-to-apply advice. , On Thursday, May 19, AudioEducator will ...
(Date:5/4/2016)... ... May 04, 2016 , ... Warren L. Smith M.D. , There is a ... plagued people since the beginning of recorded medical history, and in spite of ... It's not just a matter of inconvenience; bladder infections cost us billions of dollars ...
Breaking Medicine News(10 mins):
(Date:5/3/2016)... , May 3, 2016   Diplomat Pharmacy, Inc. (NYSE: DPLO) announced today that it is ... a video of two patients who tell their personal story and encourage those at risk ... Meet Jacque: Hepatitis C ... ... Diplomat Specialty Pharmacy (PRNewsFoto/Diplomat Pharmacy, Inc.) ...
(Date:5/3/2016)... , May 3, 2016 ... Market Size, Share, Development, Growth and Demand Forecast to ... by Field Strength (High Field, Very High Field, Low ... (Brain, Head and Neck, Spine, Musculoskeletal, Vascular, Breast, Pelvic ... global magnetic resonance imaging (MRI) market was valued at ...
(Date:5/3/2016)... , May 3, 2016 ... INTP), a clinical-stage biopharmaceutical company, today announced the appointment ... and Regulatory Affairs. "Ms. Strauss-Levy has 15 ... and has established an outstanding track record, having supported ... and regulatory approval processes in the United ...
Breaking Medicine Technology: